Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.23.3
Shareholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2023
Shareholders' Deficit (Tables) [Line Items]
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
Number of
Non-Vested
Shares
Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2022 16,970,120 $ 0.119
Granted
-
-
Shares vested (2,000,000 ) 0.021
Non-vested, September 30, 2023 14,970,120 $ 0.132
Stock Options [Member]
Shareholders' Deficit (Tables) [Line Items]
Schedule of Stock option activities Stock option activities for the nine months ended September 30, 2023 are summarized as follows:
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding, December 31, 2022 8,445,698 $ 0.40 3.43
-
Exercised
-
-
-
-
Balance Outstanding, September 30, 2023 8,445,698 $ 0.40 2.60 $
-
Exercisable, September 30, 2023 8,445,698 $ 0.40 2.60 $
-
Warrant [Member]
Shareholders' Deficit (Tables) [Line Items]
Schedule of Stock option activities Warrant activities for the nine months ended September 30, 2023 are summarized as follows:
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding December 31, 2022 34,000,000 $ 0.011 3.73 $
-
Granted
-
-
-
-
Balance Outstanding September 30, 2023 34,000,000 $ 0.011 2.99 $
-
Exercisable, September 30, 2023 34,000,000 $ 0.011 2.99 $
-